Hematolojik Malignite Hastaları, COVID-19 ve Favipiravir
Rujittika Mungmunpuntipantip1, Viroj Wiwanitkit21Private Academic Consultant, Bangkok, Thailand2D.Y. Patil University, Pune, India
Anahtar Kelimeler: COVID-19, Favipiravir
Hematological Malignancy Patients, COVID-19, and Favipiravir
Rujittika Mungmunpuntipantip1, Viroj Wiwanitkit21Private Academic Consultant, Bangkok, Thailand2D.Y. Patil University, Pune, India
Keywords: Malignancy, COVID-19, Favipiravir
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit. Hematological Malignancy Patients, COVID-19, and Favipiravir. . 2021; 38(4): 331-332
Sorumlu Yazar: Rujittika Mungmunpuntipantip, Thailand
Sorumlu Yazar: Rujittika Mungmunpuntipantip, Thailand
| ARAÇLAR |
 Tam Metin PDF Yazdır Alıntıyı İndir RIS EndNote BibTex Medlars Procite Reference Manager E-Postala Paylaş Yazara e-posta gönder
Benzer makaleler Google Scholar |